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Multiple surgical and nonsurgical approaches have been advocated for the treatment of proximal bile duct
cancer. However, survival appears longest when a resection can be performed. Fifteen patients treated at a
university center were managed with an aggressive surgical approach. Resection of the tumor was
performed in 13 of 15 patients (87%). Of the patients undergoing resection, major hepatic resection was
performed in 8 (62o70), while excision of vessels with reconstruction was performed in 5 (38%). Eleven of
the 13 resected patients (857o) were discharged from the hospital. Clinical symptoms of recurrent disease
occurred between 3 and 36 months after surgery in 7 patients, 6 of whom have died. Three other patients
are alive at 5, 21, and 36 months without clinical evidence of recurrence. There was no correlation between
the completeness of resection and the duration of disease-free survival.
These results demonstrate that radical resection of high bile duct tumors can be accomplished with an
acceptable early mortality rate, thereby extending the benefits of resection to a higher proportion of
patients. While resection is clearly effective at controlling local disease and providing palliation of jaundice,
surgical cure remains exceptional. Further improvement in the therapy of bile duct cancer must await
development of more effective multi-modality approaches.
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INTRODUCTION
Cancers involving the proximal bile ducts have been associated with a poor
prognosis. This has resulted in an attitude of "therapeutic nihilism" accepted by
many clinicians. Despite the developing consensus in the surgical literature
supporting resection of localized lesions1-6, the convenience of percutaneous or
endoscopic biliary drainage has led to widespread use of non-surgical modalitites as
primary therapy. While these non-surgical methods have been extremely valuable in
the short-term management of biliary obstruction7-9, long term results have not been
critically evaluated. Biliary-enteric anastomosis for the management of malignant
biliary obstruction was initially described by Longmire and Dogliotti and later
refined by others12-5. These experiences with internal biliary drainage have
demonstrated improved quality of life during the survival period, avoiding the
complications associated with long-term indwelling tube drainage" discomfort,
dislodgement, obstruction, and the high frequency of cholangitis.
Although there is universal support for the resection of small, localized lesions,
more extensive operations required for the removal of larger tumors have been
performed less frequently. The indications for hepatectomy in the removal of bile
duct cancers have been recently questioned by Lai et al., citing a mortality rate of
69.270 in their experience16. Although several authors have reported favorable
5 17 18 experiences with vascular reconstruction in the resection of these lesions’ the
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role of these procedures remains controversial.
In the present report we present our experience with 15 consecutive patients
referred for treatment of PBCA. Based on modern concepts of hepatic anatomy and
surgery as proposed by Couinaud19 and extended by Bismuth2, we attempted to
resect the tumor in all cases in which extra-hepatic disease was not present. The
overall resection rate was 87%. Vascular reconstruction was required in 5 of 13
resections (38%), while hepatectomy was performed in 8 of 13 (62%). These
procedures were accomplished with a hospital mortality rate of 15%. The impact of
this aggressive surgical approach on survial and palliation was reviewed.
PATIENTS AND METHODS:
Patient Selection"
Between January 1985 and June 1988, 15 consecutive patients with proximal bile duct
carcinoma were treated. All patients were evaluated at outside hospitals prior to their
referral to our institution. Prior biliary drainage had been instituted in 11 of 15
patients, either by percutaneous technique (n 6) or surgical intubation (n 5). A
single patient had received 6000R of external beam radiation to the liver 8 months
prior to evaluation in our institution. Preoperative investigation included standard
liver chemistry tests, chest radiographs and abdominal computed tomography in all
cases. Diagnostic percutaneous cholangiography was performed unless a recent
cholangiogram was available prior to therapy at the outside institution.
Arteriography was not performed systematically. Preoperative evidence of systemic
malignancy or co-existing medical conditions adding prohibitive surgical risk were
regarded as absolute contra-indications to surgery; however, these conditions were
absent in all 15 patients. Surgical Approach: All patients underwent exploration
through a right subcostal incision. Peritoneal carcinomatosis was present in two
patients and no further procedures were performed. If localized disease was present,
a bilateral subcostal incision was performed. The incision was further extended in the
midline to the xiphoid in 10 of 13 patients undergoing resection. In no case was a
thoracic incision required. The initial dissection was to encircle the common bile duct
below the tumor with skeletonization of the hepatic artery and portal vein at this
level. The dissection was then carried superiorly until the extent of vascular
involvement and local extension in the hepatic parenchyma could be determined. The
intimate relationship between the bile duct and the vessels in the hilus is clearly
depicted in figure 1. Local extension of the tumor frequently involved the right
hepatic artery, even though local intrahepatic invasion was more common on the left.
It was at this point in the dissection that the need for hepatic resection or vascular
reconstruction was assessed. Following removal of the specimen, the residual margins
of the bile ducts were examined microscopically for completeness of resection. In
cases with positive margins, further excision was performed when possible. Vessels
were reconstructed using the inferior mesenteric vein, either as a patch in cases of
partial excision of the vein wall, or as an interposition graft for arterial
reconstruction. Bile duct drainage was accomplished by the construction of Roux-en
Y cholangio-jejunostomy in all cases. When intact ducts were present, formal
mucosa to mucosa anastomosis was performed, although in four cases high
anastomoses were completed using the edge of the hepatic capsule for the anterior
wall of the suture line. Trans-hepatic stents were left in 8 cases undergoing highPROXIMAL BILE DUCT CANCER 299
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Figure 1 The anatomic proximity of the bile duct tumor to the hilar vessels is displayed. RHD right
hepatic duct, LHD left hepatic duct, RHA right hepatic artery, LHA left hepatic artery, CHD
common hepatic duct, CD cystic duct, CBD common bile duct, PHA proper hepatic artery, GDA
gastro-duodenal artery, CHA common hepatic artery, PV portal vein.
biliary anastomosis, but were removed 6 weeks postoperatively. A single patient with
a large tumour underwent total hepatectomy with orthotopic liver transplantation
(OLT); a Roux-en-Y choledocho-jejunostomy was performed.
Postoperative care: Initially patients were managed in an intensive care setting.
Controlled ventilation was maintained until the patients were alert and demonstrated
acceptable pulmonary function (usually within 6-24 hours). Patients were able to be
transferred to a routine post-surgical ward within 72 hours in all cases.
RESULTS
Descriptive Data:
Table 1. There were 9 males and 6 females with a median age of
55 years (range 43-67 years). The duration of jaundice ranged from 2 to 16 months
and, in 5 patients, chronic abdominal pain preceded the onset of jaundice. One
patient had biopsy proven cirrhosis. All patients were in good nutritional condition at
the time of assessment. Laboratory examinations revealed good synthetic liver
function with a normal prothrombin time in all cases. Serum bilirubin ranged from
0.6 to 18.8 mg/dl. Serum albumin was above 3 g/dl in all but two cases.300 J.C. EDMOND et al.
Previous Therapy:
The impact of previous therapy is demonstrated in Table 2. While surgical intubation
was most effective in relieving jaundice, these patients had the highest frequency of
cholangitis. Only of 6 patients with prior external biliary drainage had a serum
bilirubin less than 5 mg/dl, at the time of evaluation.
Operative Procedures:
Table 3 summarizes the procedures in 13 patients undergoing resection. Eight of the
13 patients underwent formal hepatectomy (62%): left hepatectomy was performed
in 6 cases, extended right hepatectomy in one, and total hepatectomy with OLT in
one. Vascular reconstructions were done in 5 of 13 (38%) patients; one other patient
underwent excision of a right hepatic artery without reconstruction. Operative time
ranged from 4 to 11 hours and blood loss averaged 5.1 units per procedure (range
1-16 units).
Early Postoperative Course:
Nine of the 13 patients (69%) developed a significant complication as listed in Table
4. There was one death 11 days postoperatively from a pulmonary embolus (patient
2). One patient suffered a near fatal pulmonary embulus which required intra-caval
filter placement. Four other patients developed clinically significant pulmonary
effusions which responded to thoracentesis or tube thoracostomy in one case.
Reoperations were performed in 4 cases; 2 after hepatectomy and 2 after bile duct
excision without hepatectomy. The patient with previous radiation developed massive
intraperitoneal hemorrhage on the seventh postoperative day. At emergency
laparotomy the hepatic artery of the remnant right liver was found to be disrupted;
the bleeding could not be controlled resulting in intraoperative death. Both patients
with carcinomatosis who underwent laparotomy without resection were discharged
from the hospital with external biliary drainage catheters in place without
complications. Overall, the hospital mortality was 13%; 15% for the 13 who
underwent resection. Among the eight patients undergoing hepatectomy mortality
was 25/0. The median hospital stay was 17.3 days (range 7-30 days).
Late Follow-up:
Followup of 13 patients discharged from the hospital has been obtained in all
patients as of Sept. 1, 1988. Both patients with carcinomatosis who did not undergo
resection died within 3 months after hospital discharge. Late survival for the 11
resected patients is presented in Table 5. Three patients are alive without clinical
evidence of disease at 5,21 and 36 months after surgery. Seven patients developed
clinical evidence of recurrence between 3 and 36 months postoperatively (median 14
months). Six of these seven patients have died of their disease between 3 and 42
months after surgery (median 18.5 months), while the other is alive with advanced
disease at 15 months. Although no quantitative analysis was possible, there was no
evident correlation between the duration of survival and the completeness of
resection as determined by examination of the surgical specimen. One patient died of
a pulmonary embolus 7 months following curative resection. At autopsy, no residual
tumor was present. Table 6 presents the clinical findings of the seven patients whoPROXIMAL BILE DUCT CANCER 301
Table 1 Pre-operative clinical and laboratory findings
Observation
Number of patients
Age (yrs)
Duration of symptoms (months)
Sex (M/F)
Previous surgery (present/absent)
Cholangitis (present/absent)
Cirrhosis (present/absent)
Laboratory data:
AST (I.U./1)
Bili (mg/dl)
Prothrombin time (secs)
Albumin (g/dl)
Alk phos (I.U./1)
15
55 (43-67)
4 (2-16)
9/6
6/9
6/9
1/14
59 (10-449)
9.4 (0.6-18.8)
12.5 (11.4-13.7)
3.4 (2-3.9)
366 (127-727)
a. Categorical data presented numbers, continuous data median, (range).
Table 2 Effect of previous biliary drainage on the presence of cholangitis and the relief of jaundice.
Treatment No. ofpatients Reliefofjaundice Cholangitis
None
b
Percutaneous
drainage
Laparotomy
with surgical
intubation
4 0
6 2
5 3 3
Serum bilirubin < mg./dl
b. One patient underwent laparotomy without biliary drainage.
Table 3 Operative Procedures in Patients Undergoing Resection
Patient Hepatectomy Vascular Repair
b Biliary repair Curativea
4,5,6,7,8
2 1,2,3,4
4 1,2,3,4 IVC patch
5 1,2,3,4 Portal vein patch
6 Total Transplant
7 RHA (vein graft)
8 1,2,3,4
9
10 1,2,3,4 RHA (vein graft)
12
13 RHA ligated
14 1,2,3,4
15
a. Hepatic segments according to Couinaud
b. PV Portal vein, HA hepatic artery, IVC inferior cava
HJ hepatico-jejunostomy
d. + microscopic margins negative
LHJ
RHJ
RHJ
RHJ (2 ducts)
HJ
HJ (3 ducts)
RHJ
HJ
RHJ (2 ducts)
HJ
HJ (3 ducts)
RHJ
HJ (2 ducts)302 J.C. EDMOND et al.
Table 4 Postoperative course of resected patients
Patien Complication Hospital days Survival
Pleural effusion
Fatal pulmonary embolus
Atelectasis, pleural effusion
Steroid responsive rejection
10.
14.
15.
Reoperation: subphrenic abscess
pleural effusion
Reoperation: biliary fistula
pleural effusion
Pulmonary embolus
Reoperation: postoperative
intestinal obstruction
Reoperation: postoperative
hemorrhage
+ discharged home
Table 5 Late course of patients surviving resection
30
11
24
30
21
17
8
30
26
15
21
18
Patient Curative Recurrence
b Survival
1. yes 36
4. no
5. yes 14
6. yes 3
7. yes 16
8. yes
9. no 14
10. yes
12. no 9
13. no 3
15. no
Curative negative microscopic margin of resected specimen
b. Date of clinical recurrence (months).
Survival time (months) and status of Sept. l, 1988
42 (died)
36 (alive)
19 (died)
3 (died)
21 (died)
21 (alive)
18 (died)
7 (died)
15 (alive)
5 (died)
5 (alive)
developed recurrence. Gastro-intestinal complications developed in 4 patients as the
first sign of recurrence. These complications occurred between 3 and 16 months
postoperatively and were difficult to manage. All four patients subsequently died
within 6 months of inanition. Another developed pulmonary metastases. Of interest,
none of these five patients developed recurrent jaundice. The patients who received
OLT developed diffuse metastatic disease and died 3 months following surgery. Only
patient developed jaundice as the first sign of recurrence. This patient has remained
symptomatic despite repeated attempts at endoscopic and percutaneous biliary
drainage and is currently alive with progressive inanition.PROXIMAL BILE DUCT CANCER 303
Table 6 Clinical presentation of late recurrence
Patient Time Finding
1. 36 Hepatic mass, pulmonary
metastases
5. 14 Gastric outlet obstruction
6. 3 Bone and pulmonary
metastases
7. 16 Gastric outlet obstruction
9. 14 Duodenal hemorrhage
12. 9 Cholangitis, jaundice
13. 3 Small bowel obstruction,
carcinomatosis
Time months after surgery
DISCUSSION
The rate of surgical resection in this series is, to our knowledge, the highest reported
in the literature on therapy of high bile duct cancers. In addition, the high rate of
hepatic resection (6270) and vascular reconstruction (3870) attests to the extensive
local involvement of many of the lesions treated. The 15 patients represent a
consecutive series, all of whom were referred for treatment from outside hospitals.
There was perhaps a bias toward referral of patients with more extensive lesions;
however, this selection is typical of all centers with experience in the treatment of
biliary tumors. The difficulty of assessing the extent of involvement with
preoperative testing also mitigates against the possibility of selective referral. The
high resection rate most likely reflects our willingness to perform extensive resection
to remove local disease. This was accomplished with a 15070 hospital mortality rate
for resections, an experience comparable to other published series.
Since the initial description of these tumors as a clinical entity by Klatskin21, it has
been difficult to determine the natural history of the proximal bile duct cancers. In
general, slow growth has been characteristic of these lesions, and jaundice usually
precedes clinically evident manifestations of systemic disease. This was true in our
patients with only 2 of 15 (13070) having peritoneal dissemination at the time of
surgery. Since tumor growth is slow, effective treatment of the jaundice is the
essential component of palliation. Although short-term control of icterus with
external or endoscopic means of biliary drainage is possible7-9, the quality of life has
been poor due to the frequent problems inherent in tube drainage of the biliary tree.
In our series (Table 2), preoperative external biliary drainage was rarely successful in
clearing jaundice, and although surgical intubation was more effective, the high
incidence of cholangitis after surgical intubation is a significant concern. Others,
however, have reported more favorable experiences with surgical placement of biliary
6 22 23 stents and long-term intubation
Early postoperative complications were frequent in our patients due to the
extensiveness of the operative procedures. Pulmonary effusions were the most
frequent but were managed with aspiration in most cases. Pulmonary embolization
occurred in the postoperative period in two patients one of whom died. Another
patient with a curative resection died 6 months postoperatively from a pulmonary304 J.C. EDMOND et al.
embolus. Although our experience is small, this observation suggests that patients
with biliary cancer may be a high-risk group for venous thrombo-embolic
complications. The second death in the postoperative period occurred in a patient
with previous radiation therapy due to disruption of the hepatic artery. Because of its
effects on tissue healing, preoperative radiation may increase surgical risk in patients
who require major hepatic resection for removal of the tumor.
Because of the absence of effective systematic therapy of bile duct cancer and the
poor results of tube drainage, surgical therapy with internal biliary drainage has
become the mainstay of both curative and palliative therapy of these lesions 1-6’12-15.
In our experience resection of bile duct tumors were extremely effective in relieving
jaundice. Since excision of involved vessels and liver parenchyma was performed,
resection was possible in all the patients with disease confined to the liver, making it
possible to establish internal biliary drainage.
While resection for cure is rarely possible, most groups have observed a small
number of long term survivors with resection. Significantly improved survival for
resected patients is probably one possible using extremely strict criteria which would
exclude at least 8070 of patients 1. The decision to perform palliative resection is
complicated by the difficulty of assessing the extent of intra-hepatic extension prior
to completion of the resection. In favor of palliative resection is the observation of
.prolonged symptom-free survival in some patients despite the histologic
demonstration of residual disease. The impact of our aggressive approach on survival
is difficult to determine. Overall follow-up is short in the present series; however, no
patient appears to have been cured. As demonstrated in Table 5, most patients with
palliative resection were disease-free for at least one year. The earliest recurrence
occurred in the patient receiving OLT. Recurrence was most often associated with
gastrointestinal symptoms (Table 6), either due to duodenal obstruction or malignant
intestinal obstruction associated with carcinomatosis. These patients were difficult to
manage and usually survived several months with chronic pain and development of
progressive inanition.
In conclusion, the primary advantage of our approach of radical surgical excision
is the extension of the possibility of cure or prolonged palliation to a larger
proportion of patients with bile duct cancer. All resected patients were free of
jaundice at the time of discharge and enjoyed symptom free survival for varying
intervals. Although our experience with liver transplantation for biliary cancer is
confined to a single patient, the experience of early systemic spread despite an
apparently curative resection is consistent with other observations of OLT in
malignant disease24’25. At present, based on our experience and a review of the
literature, resection of the lesion with conventional surgical techniques for removal of
gross disease provides effective palliation and, additionally, the chance is cure in a
small proportion of patients. Postoperative radiation therapy, either using external
beam or intra-biliary stents26, may have added benefit although the impact of these
modalities is difficult to determine due to variability of the natural history of this
disease. More effective therapy of bile duct cancer must clearly await progress in
radiation or chemotherapeutic modalities to supplement surgical removal.
References
1. Bismuth, H., Castaing, D. and Traynor, O. (1988). Resection or palliation: priority of surgery in the
treatment of hilar cancer. World Journal of Surgery, 12, 39-47.PROXIMAL BILE DUCT CANCER 305
2. Evander, A., Fredlund, P., Hoevels, J., Ihse, I. and Bengmark, S. (1980) Evaluation of agressive
surgery for carcinoma of the extrahepatic bile ducts. Annals of Surgery, 191, 191-223.
3. Launois, B., Campion, J.P., Brissot, P. and Gosselin. (1979) Carcinoma of the hepatic hilus. Surgical
management and the case for resection. Annals of Surgery, 190, 151-157.
4. Fortner, J.G., Kallum, B.O. and Kim, D.K. (1976) Surgical management of carcinoma of the junction
of the main hepatic ducts. Annals of Surgery, 184, 68-73.
5. Blumgart, L.H., Benjamin, I.S., Hadjis, N.S. and Beazley, R. (1984) Surgical approaches to
cholangiocarcinoma at the confluence of hepatic ducts. Lancet, i, 66-70.
6. Cameron, J.L., Broc, P. and Zuidema, G.D. (1982) Proximal bile duct tumors. Annals of Surgery,
196, (4) 412-419.
7. Cotton, P.B. (1982) Duodenoscopic placement of biliary prostheses to relieve malignant obstructive
jaundice. British Journal of Surgery, 69, 501-503.
8. Huibregtse, K. and Tytgat, G.N. (1982). Palliative treatment of obstructive jaundice by transpapillary
introduction of large bore bile duct endoprosthesis. Gut, 23, 371-375.
9. Freeny, P.C., Gannon, R.M. and Ball, T.J. (1982) Endoscopic retrograde biliary drainage. American
Journal of Radiology, 139, (8) 399-401.
10. Longmire, W.P. and Sanford, M.C. (1948) Intrahepatic cholangiojejunostomy with partial
hepatectomy for biliary obstruction. Surgery, 24, 264-76.
11. Dogliotti, A.M. (1951) Zur operations technik bei verschluss der extrahepatischen gallenwege.
Langenbecks. Arch. Klin. Chir., 270, Kongrassbericht, 101-103.
12. Soupault, R. and Caroli J. (1955) Cancer du canal hepatique. Un nouveau procede d’hepato-
cholangio-jejunostomie. Memoirs de l’Academie de Chirurgie, $1, 902-908.
13. Bismuth, H. and Corlette M.B. (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the
hilus of the liver. Surgery, Gynecology and Obstetrics, 140, (1) 170-178.
14. Cameron, J.L., Gaylek, B.W. and Harrington, D.P. (1978) Modification of the Longmire procedure.
Annals of Surgery, 187, (4) 379-382.
15. Malt, R.A., Warshaw, A.L., Jamieson, C.H. and Hawk J.C. (1980) Left intrahepatic
cholangiojejunostomy for proximal obstruction of the biliary tract. Surgery, Gynecology and
Obstetrics, 150, (2) 193-197.
16. Lai, E.C.S., Tompkins, R.K. Roslyn, J.J. and Mann L.L. (1987) Proximal bile duct cancer. Annals of
Surgery, 205, (2) 111-118.
17. Sagakuchi, S. and Nakamura, S. (1986) Surgery of the portal vein in resection of cancer of the hepatic
hilus. Surgery, 99:. 344-349.
18. Lygidakis, N.J., van der Heyde, M.N., van Dongen, R.J., Kromhout, J.G., Tytgat, G.N. and
Huibregtse, K. (1988) Surgical approaches for unresectable primary carcinoma of the hepatic hilus.
Surgery, Gynecology and Obstetrics, 166: 107-114.
19. Couinaud, C. (1957) Le foie: etudes anatomiques et chirurgicales. Paris: Masson.
20. Bismuth, H. (1982) Surgical anatomy and anatomical surgery of the liver. World Journal of Surgery,
6: 3-9.
21. Klatskin, G. (1965) Adenocarcinoma of the hepatic duct at its bifurcation with the porta hepatis.
American Journal of Medicine, 38, (2) 241-256.
22. Praderi, R.C., Estefan, A.F. and Tiscornia, E. (1985) Transhepatic intubation in benign and
malignant lesions of the biliary ducts. Current Problems in Surgery, Ravitch M.M, ed., 22: (12).
23. Terblanche, J., Saunders, S.J. and Louw, J.H. (1972) Prolonged palliation in carcinoma of the main
hepatic duct junction. Surgery, 71, (5) 720-731.
24. Calne, R.Y. (1982) Liver transplantation for liver cancer. World Journal of Surgery, 6 (1) 76-80.
25. Iwatsuki, S.L., Klintmalm, G.B. and Starzl, T.E. (1982) Total hepatectomy and liver replacement
(orthotopic liver transplantation) for primary hepatic malignancy. World Journal ofSurgery, 6, 81-85.
26. Conroy, R.M., Shahbazian, A.A., Edwards, K.C., Moran, E.M., Swingle, K.F., Lewis G.J. and
Pribram F.W. (1982) A new method for treating carcinomatous biliary obstruction with intracatheter
radium. Cancer, 49, (7) 1321-1327.
Accepted by S. Bengmark on 6 November 1988
INVITED COMMENTARY
The authors recommend radical surgical resection of proximal bile duct cancer
whenever possible provided that it can be accomplished with a low operative
mortality rate because they believe this offers the best survival potential and quality306 J.C. EDMOND et al.
of life. In 10 patients, 9 of whom underwent resection, with a mean follow-up of 12.5
months, they report a 5007o disease free survival and a 707o survival rate. The quality
of survival is difficult to discern from the data presented.
The Cape Town group have recently presented a different viewpoint based on
long-term follow-up of a consecutive group of patients treated palliatively, usually
with U-tube intubation1. This summary of the Cape Town data and conclusions is
presented to help achieve perspective in assessing controversies surrounding the
management of high bile duct carcinoma. Our group studied 21 patients with
cholangiocarcinoma at the confluence of the main right and left hepatic ducts seen
consecutively in the period from 1968 to 1982 and evaluated, treated and documented
prospectively with follow-up until mid-1986. All tumours were deemed irresectable.
The U-tube palliative bypass was developed during this study and used in 14 patients.
Histological confirmation of the diagnosis was obtained in 71% patients and seven
patients received radical radiotherapy as additional treatment. The 30 day overall
hospital mortality was 19070 with a one and two year actual survival of 57070 and 33070
respectively. The quality of life was usually good. The Cape Town paper concluded
that radical resection was seldom possible and advocated U-tube palliative
management in the majority of patients.
The need to obtain histological confirmation of the diagnosis is generally accepted
today. The rare papillary tumours, which tend to grow into the lumen of the bile duct
and which have a better prognosis, must be resected whenever possible. The question
is whether radical resection is able to eradicate the usual scirrhous type carcinoma.
The answer is probably ’no’ in most instances thus the role of radical resection must
be questioned, unless it can be accomplished with minimal mortality as in the
Chicago study. Weinbren and Mutum studied resected material at the Hammersmith
Hospital, London, and emphasised the tendency of this carcinoma to spread locally,
often beyond the confines of the macroscopic limits of the tumour. Nerve
involvement was common and the growth tended to spread to the liver between the
hepatocyte plates and also along the bile ducts both within the wall and at times
beneath apparently normal intact lining epithelial cells. The biological nature of this
carcinoma which tends to spread beyond the confines of radical local surgery2, may
well ultimately defeat the surgeon’s enthusiasm for resection. In reviewing a recent
paper Adson summarised the situation by stating that in the setting of a condition
that is seldom cured by heroic resection one has to "decide whether what can be
done, should or should not be done’’3.
The management options remain controversial in 1988. There have been a
surprising number of reports advocating radical resection for this tumour1. The
alternatives to radical resection are operative dilatation with intubation either using a
U-tube as advocated by the Cape Town group1, or a straight tube as recommended
by others4, or operative bypass using the round ligament approach or finally
endoprosthesis insertion. Any of these techniques may be combined with radical
radiotherapy. The author favours radiotherapy although the evidence remains
circumstantial1. Endoprostheses have proved problematic because of the long
survival of these patients leadcing to repeated blockage together with the difficulty of
insertion in high bile duct lesions. Liver transplantation remains unjustified because
of disappointing results due to recurrence of tumours when compared with the
excellent palliation that can be achieved with simple therapy. In assessing the results
of radical resection it must be remembered that almost all of the enthusiastic reports
have had a short follow-up and that with longer follow-up an increasing number ofPROXIMAL BILE DUCT CANCER 307
the patients ultimately die of the underlying tumour6. The longterm follow-up from
Los Angeles has indicated that the quality of survival is similar with either curative
resection or intubation7. Two major American studies have emphasised that resection
of the bile duct is only justified if this can be achieved without hepatic resection4’7.
Our group have reported the results of palliative therapy in consecutive unselected
patients including operative dilatation and U-tube placement with or without
radiotherapy and demonstrated as good survival as that achieved in many major
series of selected patients undergoing radical resection1. The author concedes that the
only chance of cure is radical surgical resection but believes that this is seldom
possible. He agrees with the Los Angeles group that resection should only be
recommended when it can be performed without concomitant hepatic resection7.
Both easily resectable lesions and patients with papillary carcinoma are unfortunately
relatively uncommon but must be sought out. If good results are to be achieved, this
difficult group of patients must be referred to specialist centres with a particular
interest in high bile duct carcinoma.
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